Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1995-01-17
1996-08-20
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
424479, 514171, A61K 936, A61K 3156, A61K 31565, A61K 3157
Patent
active
055479480
ABSTRACT:
A sugar coating composition for application to a compressed medicinal tablet comprising a sugar, a dose of a hormonal steroid and a steroid release rate controlling amount of microcrystalline cellulose.
REFERENCES:
patent: 3437728 (1969-04-01), Renwanz et al.
patent: 3980766 (1976-09-01), Shaw
patent: 4154820 (1979-05-01), Simoons
patent: 4248856 (1981-02-01), Guley et al.
patent: 4309404 (1982-01-01), DeNeale et al.
patent: 4309405 (1982-01-01), Guley et al.
patent: 4327076 (1982-04-01), Puglia et al.
patent: 4390531 (1983-06-01), Edgren
patent: 4415546 (1983-11-01), Ramachandran
patent: 4415547 (1983-11-01), Yu
patent: 4425339 (1984-01-01), Pitchford
patent: 4720387 (1988-01-01), Sakamoto
patent: 4755386 (1988-07-01), Hsiau et al.
patent: 4826831 (1989-05-01), Plunkett et al.
patent: 4927816 (1990-05-01), Ester
patent: 5073374 (1991-12-01), McCarty
patent: 5108995 (1992-04-01), Casper
patent: 5208225 (1993-05-01), Boissunneault et al.
patent: 5213808 (1993-05-01), Bar-Shalom et al.
patent: 5223268 (1993-06-01), Stetsko et al.
patent: 5340589 (1994-08-01), Stetsko et al.
patent: 5384130 (1995-01-01), Kamada
CA114 (18): 171312e.
CA113 (14): 120828z.
CA113 (2): 12183b.
CA111 (24): 219315a.
CA110 (24): 219101g.
CA110 (14): 121381y.
CA111 (20): 180687w.
CA106 (22): 182638b, 1988.
CA103 (8): 59333j, 1990.
CA 103 (8): 59308e, 1989.
CA 102(12): 100833s, 1991.
CA 100(24): 197789b, 1990.
CA 100 (12): 91412h, 1990.
CA85 (20): 149150m, 1988.
Wyeth-Ayerst "Prem Phase".TM. Conjugated Estrogens Tablets/Medroxyprogesterene Acetate Tablets (1995).
Wyeth-Ayerst "Prempro".TM. Conjugated Estrogens Tablets/Medroxyprogesterene Acetate Tablets (1995).
American Home Products Corporation
Jackson Richard K.
Rose Shep K.
LandOfFree
Controlled release of steroids from sugar coatings does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release of steroids from sugar coatings, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release of steroids from sugar coatings will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2330851